Geptanolimab - CAS 2348469-43-0

Geptanolimab (CBT-501) is a humanized IgG4κ monoclonal antibody directed against PD-1 (Programmed Death-1) . Geptanolimab functions by competitively blocking the binding of PD-L1 and PD-L2 to PD-1, thereby reactivating T cell activity. Geptanolimab is under development as an immunotherapeutic agent with potential applications in cancer treatment.

PD-1/PD-L1

Apoptosis, Cell Cycle/Checkpoint, Immunology/Inflammation

2348426

0.995

-20°C

Ice Packs

Inhibitory Antibodies